Skip to main content

Qsymia News

Few Adolescents With Obesity Prescribed Obesity Medications

FRIDAY, June 13, 2025 – Despite an increase in the prevalence of prescribing, only 0.5 percent of U.S. adolescents with obesity were prescribed an obesity medication in 2023, according to research...

FDA Approves Qsymia for Chronic Weight Management in Certain Pediatric Patients Aged 12 years and Older

June 27, 2022 – The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Weight Loss (Obesity / Overweight)

Qsymia patient information at Drugs.com